
Medicine and Health
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants
W. Tai, S. Feng, et al.
This innovative study by Wanbo Tai and colleagues introduces a groundbreaking mRNA-based vaccine that effectively targets conserved regions of the SARS-CoV-2 virus. By focusing on T-cell responses and combining it with existing RBD-based vaccines, this research shows promising results against emerging variants, underscoring the importance of robust immune response for effective COVID-19 vaccination.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.